First Avenue Limited

Touyun Biotech (1332) discloses ownership of "Purchaser B" in its sale of Hope Capital LtdPrevious announcement
Company announcement, 12-Nov-2021
Cordoba Homes Ltd is 61.99% owned by "a private family trust with Mr. Eugene Chuang as the sole beneficiary" and 28.08% owned by China Evergrande (3333). The other 9.93% is owned by "an independent third party". Note: we've been tracking Cordoba for years as part of the "Chung Nam Network". Various listed companies have held stakes in Cordoba Homes, but this is the first time we've seen China Evergrande as a shareholder.
Touyun Biotech (1332) subsidiary sells Hope Capital Ltd to Imagi (0585), Oshidori (0622), Cordoba Homes (30% each) and David Ki (10%) for HK$160mImagi announcement
Company announcement, 1-Nov-2021
The vendor, Galaxy Vantage Ltd, is 61.01% owned by Touyun Biotech, 27.29% owned by Blue River (0498) and 11.71% by David Ki. Oshidori owns 28.53% of Blue River and 21.31% of Imagi. The target owns Hope Securities Ltd. The ownership of Cordoba Homes Ltd is not disclosed. Mr Ki previously sold Hope Capital Ltd to the vendor in a share-swap transaction which completed on 10-Dec-2020, less than a year ago. All the listed companies and Cordoba are in what we call the "Chung Nam Network", members of which frequently deal with each other.
Planetree (0613) subsidiary Planetree (Cayman) Capital Ltd (formerly Liberty Capital Ltd) buys out remaining minoritiesCTT announcement
Company announcement, 4-Aug-2020
9.8% comes from Oshidori (0622) and 8.0% from China Touyun Tech (1332), at a total price of HK$93.6m ($117,000 per share).
Planetree (0613): supplemental disclosure on the other holders of Liberty Capital Ltd
Company announcement, 14-Feb-2020
Referring to its earlier announcement of a capital injection into Liberty Capital Ltd, Planetree now confirms the identity of the other holders. "Investor A" is Oshidori (0622) and "Investor B" is China Touyun Tech (1332). We note that Oshidori first mentioned the subscription of 440 shares in its interim results on 28-Aug-2019, and CTT first mentioned the subscription of 360 shares in its interim results on 23-Aug-2019. There is still no explanation of how the issued shares were reduced from 3800 to 2800 before the capital injection.

Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top